Laboratory Corp. (LH) Tops Q4 EPS by 3c; Guides FY12
Laboratory Corp. (NYSE: LH) reported Q4 EPS of $1.56, $0.03 better than the analyst estimate of $1.53. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.38 billion.
Sees FY2012 EPS of $6.75-$7.05, versus the consensus of $6.93.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Sees FY2012 EPS of $6.75-$7.05, versus the consensus of $6.93.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
